Table 1.

Comparison of putative CTCs assayed by Nanowell (both TERT and MET positivity) and conventional ICC

Patient ID	Nanowell	ICC	Types	Lung cancer stage
1	39	0	NSCLC	I
2	21	4	NSCLC	II
3	15	1	NSCLC	I
4	14	6	NSCLC	I
5	11	0	NSCLC	III
6	9	0	NSCLC	II
7	9	0	NSCLC	I
8	9	0	NSCLC	IV
9	7	0	NSCLC	I
10	7	7	NSCLC	IV
11	7	0	NSCLC	II
12	0	0	Healthy	N/A

Markedly, the Nanowell assay’s analytical sensitivity exceeded that of conventional ICC for putative CTC detection in NSCLC patients. More information can be found in Table S2.